Ralfinamide mesylate

CAS No. 202825-45-4

Ralfinamide mesylate( FCE-26742A (mesylate) )

Catalog No. M20790 CAS No. 202825-45-4

Ralfinamide mesylate is an orally available Na+ channel blocker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 259 Get Quote
10MG 405 Get Quote
25MG 668 Get Quote
50MG 888 Get Quote
100MG 1251 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ralfinamide mesylate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ralfinamide mesylate is an orally available Na+ channel blocker.
  • Description
    Ralfinamide mesylate is an orally available Na+ channel blocker.
  • In Vitro
    ——
  • In Vivo
    Ralfinamide (30 mg/kg, 60 mg/kg; p.o.; twice daily; 42 days) treated with Ralfinamide (80 mg/kg; p.o.; twice daily; 7 days) preoperatively suppresses neuropathic pain. Animal Model:81 adult male Sprague–Dawley male rats (260–460 g) Dosage:80 mg/kg (7 days preoperatively), 30 mg/kg, 60 mg/kg (postoperative)Administration:Oral gavage; twice daily; until postoperative day 42 Result:Suppressed neuropathic pain.
  • Synonyms
    FCE-26742A (mesylate)
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    202825-45-4
  • Formula Weight
    398.45
  • Molecular Formula
    C18H23FN2O5S?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(NCc1ccc(OCc2ccccc2F)cc1)C(N)=O.CS(=O)(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liang X Yu G Su R . Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain[J]. European journal of pharmacology 2018 823:27-34.
molnova catalog
related products
  • SM-6586

    SM-6586 is a potent calcium channel antagonist with inhibitory effects on Na+/H+ and Na+/Ca2+ exchange channels, and can be used in the study of cerebrovascular disease and hypertension, among other diseases.

  • Lidocaine hydrochlor...

    Lidocaine HCl salt, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo.

  • Levobupivacaine

    Levobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted pipecoloxylidide.